Olema Pharmaceuticals, Inc.
OLMA
$10.63
$0.121.14%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -204.57M | -185.15M | -162.45M | -149.96M | -142.30M |
| Total Depreciation and Amortization | 451.00K | 481.00K | 490.00K | 419.00K | 471.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 27.80M | 19.08M | 12.47M | 14.05M | 14.74M |
| Change in Net Operating Assets | 11.58M | 16.86M | 2.78M | 814.00K | -73.00K |
| Cash from Operations | -164.74M | -148.72M | -146.72M | -134.67M | -127.16M |
| Capital Expenditure | -221.00K | -- | -- | 0.00 | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -99.32M | -106.15M | -155.76M | -108.00M | -79.35M |
| Cash from Investing | -99.54M | -106.15M | -155.76M | -108.00M | -79.35M |
| Total Debt Issued | 0.00 | 3.00M | 3.00M | 3.00M | 3.00M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 281.48M | 278.06M | 227.92M | 252.06M | 252.11M |
| Repurchase of Common Stock | -7.94M | -4.41M | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -13.14M | -19.87M | -19.62M | -13.01M | -13.01M |
| Cash from Financing | 260.40M | 256.78M | 211.30M | 242.05M | 242.10M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.87M | 1.91M | -91.18M | -628.00K | 35.58M |